Related Experiment Videos

Effect of electroconvulsive therapy on hematological parameters

S Chaturvedi1, R K Chadda, U Rusia

  • 1Department of Pathology, Institute of Human Behaviour and Allied Sciences, Delhi 110 095, India. cvsujata@id.eth.net

Psychiatry Research
|December 1, 2001
PubMed

Insights

Electroconvulsive therapy (ECT) can cause significant changes in total leukocyte count and hemoglobin levels. Further research is needed to understand the implications of these hematological effects.

Area of Science:

  • Psychiatry
  • Hematology

Background:

  • Electroconvulsive therapy (ECT) is a psychiatric treatment.
  • Complete blood count is a routine pre-ECT evaluation.
  • No known hematological contraindications for ECT exist.

Purpose of the Study:

  • To investigate the hematological effects of electroconvulsive therapy (ECT).
  • To analyze changes in various blood parameters following ECT.

Main Methods:

  • A preliminary study involving 31 psychiatric patients undergoing ECT.
  • Blood samples collected pre-ECT and at 0, 1, and 2 hours post-ECT.
  • Analysis of hemoglobin (Hb%), total and differential leukocyte count (TLC/DLC), RBC, MCV, MCH, MCHC, and platelet count using a Sysmex K-1000 analyzer.

Main Results:

  • Significant changes observed in TLC, differential leukocyte counts (polymorphs and lymphocytes), and Hb%.
  • No statistically significant changes noted in other measured hematological parameters.
  • Preliminary findings indicate potential hematological alterations associated with ECT.

Conclusions:

  • ECT may induce transient changes in specific hematological parameters, notably white blood cell counts and hemoglobin.
  • Further studies are required to confirm these findings and elucidate the underlying mechanisms and clinical relevance.
  • These hematological effects warrant consideration in the comprehensive understanding of ECT's impact.

Related Concept Videos